Livforsakringsbolaget Skandia Omsesidigt Raises Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Livforsakringsbolaget Skandia Omsesidigt grew its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 116.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,216 shares of the pharmacy operator’s stock after purchasing an additional 1,729 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Walgreens Boots Alliance were worth $84,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. EverSource Wealth Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 308.4% during the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 845 shares during the last quarter. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. Venturi Wealth Management LLC boosted its position in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after acquiring an additional 981 shares during the last quarter. FinTrust Capital Advisors LLC boosted its position in shares of Walgreens Boots Alliance by 2,314.5% during the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 1,273 shares during the last quarter. Finally, Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $30,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Trading Up 3.7 %

Shares of WBA opened at $18.24 on Friday. The company’s fifty day simple moving average is $20.42 and its 200-day simple moving average is $21.93. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The company has a market cap of $15.74 billion, a P/E ratio of -2.61, a P/E/G ratio of 1.09 and a beta of 0.73. Walgreens Boots Alliance, Inc. has a twelve month low of $17.51 and a twelve month high of $36.14.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion for the quarter, compared to analysts’ expectations of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.16 earnings per share. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 EPS for the current year.

Insider Transactions at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Walgreens Boots Alliance news, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction on Tuesday, April 2nd. The shares were bought at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 13,456 shares of company stock worth $270,423. Insiders own 17.40% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. TD Cowen decreased their price target on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. HSBC reaffirmed a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Finally, Barclays assumed coverage on shares of Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 price target on the stock. Four investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $24.36.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.